Amid vaccine hoarding criticism, Biden admin plots $2.7 billion manufacturing push
Amid vaccine hoarding criticism, Biden admin plots $2.7 billion manufacturing [...]
Amid vaccine hoarding criticism, Biden admin plots $2.7 billion manufacturing [...]
Fierce Pharma Asia—Sourcing Moderna’s COVID vaccine contaminant; Astellas’ gene therapy [...]
First Biogen, now the FDA: Congressional Democrats request agency records [...]
After criticism, Johnson & Johnson COVID-19 vaccines shipped from South [...]
JAK inhibitors from Pfizer, AbbVie and Lilly hit with dreaded [...]
Sanofi pulls Epilim website after U.K. regulator points out consumer [...]
Merck’s Keytruda survives FDA scrutiny in bladder cancer, but ends [...]
AbbVie’s Imbruvica patent win sets up solid growth path after [...]
Key vaccine leaders departing FDA as COVID-19 booster questions linger [...]
FDA approval of Pfizer’s COVID-19 vaccine spurs American confidence: Harris [...]